Effects of aging on muscle fibre type and size.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanistic concepts and prior literature without systematic review methodology.
PubMed 15462613 · doi:10.2165/00007256-200434120-00002
What was done
This is a narrative review synthesizing published evidence on the cellular and physiological mechanisms underlying age-related muscle mass loss (sarcopenia), focusing on muscle fiber type, size, motor unit denervation, and endocrine and inflammatory signaling.
What was found
The abstract reports descriptive mechanisms without quantitative metrics or statistical values. Muscle mass loss begins around age 50 and accelerates past age 60. The primary driver of sarcopenia is a decrease in total muscle fiber number, alongside selective atrophy of type II muscle fibers. Contributing physiological mechanisms include motor unit loss through denervation, decreased anabolic hormones (testosterone, growth hormone, and insulin-like growth factor-1), and increased catabolic cytokines (specifically interleukin-6).
Why it matters
It consolidates understanding of how cellular-level muscle fiber loss and hormonal shifts drive muscle weakness, falls, and metabolic decline in older adults.
Limits
As a narrative review, it lacks a systematic search protocol, risk of bias assessment, or quantitative data synthesis. No sample sizes or effect sizes are provided in the abstract.
Cited by
- supports During aging and sedentary behavior, innervating motor units die off, accompanied by a selective reduction in Type II fast-twitch fibers and a relative increase in slow-twitch fibers.